Results 1 - 20 of 13,771 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
Journal Title:
Gynecologic Oncology
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
A personalized probabilistic approach to ovarian cancer diagnosticsGynecologic oncology, 2024-03, Vol.182, p.168 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.030 ;PMID: 38266403Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
Distribution and prognostic role of BRCA status in elderly ovarian cancer patientsGynecologic oncology, 2024-03, Vol.182, p.57 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.022 ;PMID: 38262239Digital Resources/Online E-Resources |
| 3 |
Material Type: Article
|
|
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo studyGynecologic oncology, 2024-03, Vol.182, p.179 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.049 ;PMID: 38335900Digital Resources/Online E-Resources |
| 4 |
Material Type: Article
|
|
History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme studyGynecologic oncology, 2024-03, Vol.182, p.1 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.024 ;PMID: 38246041Digital Resources/Online E-Resources |
| 5 |
Material Type: Article
|
|
Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classificationGynecologic oncology, 2024-03, Vol.182, p.148 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.006 ;PMID: 38266401Digital Resources/Online E-Resources |
| 6 |
Material Type: Article
|
|
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York StateGynecologic oncology, 2024-03, Vol.182, p.141 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.004 ;PMID: 38262237Digital Resources/Online E-Resources |
| 7 |
Material Type: Article
|
|
Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysisGynecologic oncology, 2024-03, Vol.182, p.99 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.018 ;PMID: 38262245Digital Resources/Online E-Resources |
| 8 |
Material Type: Article
|
|
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceGynecologic oncology, 2024-03, Vol.182, p.51 [Peer Reviewed Journal]Copyright © 2023. Published by Elsevier Inc. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.008 ;PMID: 38262238Digital Resources/Online E-Resources |
| 9 |
Material Type: Article
|
|
Hypertension associated with niraparib in cancer patients: A pharmacovigilance analysis based on the FAERS database and meta-analysis of randomized controlled trialsGynecologic oncology, 2024-03, Vol.182, p.108 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.012 ;PMID: 38295607Digital Resources/Online E-Resources |
| 10 |
Material Type: Article
|
|
UCHL-3 as a potential biomarker of ovarian cancerGynecologic oncology, 2024-03, Vol.182, p.156 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.031 ;PMID: 38266402Digital Resources/Online E-Resources |
| 11 |
Material Type: Article
|
|
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomesGynecologic oncology, 2024-03, Vol.182, p.32 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.015 ;PMID: 38246044Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapyGynecologic oncology, 2024-03, Vol.182, p.39 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.017 ;PMID: 38246045Digital Resources/Online E-Resources |
| 13 |
Material Type: Article
|
|
Authentic leadership in action: Experience gained from a gynecologic oncology fellowship leadership curriculumGynecologic oncology, 2024-03, Vol.182, p.176 [Peer Reviewed Journal]EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.036 ;PMID: 38330810Digital Resources/Online E-Resources |
| 14 |
Material Type: Article
|
|
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerGynecologic oncology, 2024-03, Vol.182, p.124 [Peer Reviewed Journal]Copyright © 2023. Published by Elsevier Inc. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.017 ;PMID: 38262235Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)Gynecologic oncology, 2024-03, Vol.182, p.75 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.028 ;PMID: 38262242Digital Resources/Online E-Resources |
| 16 |
Material Type: Article
|
|
Destigmatizing gynecologic cancers and prioritizing prospective radiotherapy studiesGynecologic oncology, 2024-03, Vol.182, p.121 [Peer Reviewed Journal]EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.011 ;PMID: 38262234Digital Resources/Online E-Resources |
| 17 |
Material Type: Article
|
|
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignanciesGynecologic oncology, 2024-03, Vol.182, p.63 [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.025 ;PMID: 38262240Digital Resources/Online E-Resources |
| 18 |
Material Type: Article
|
|
Reduced healthcare access contributes to delay of care in endometrial cancerGynecologic oncology, 2024-03, Vol.182, p.115 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.010 ;PMID: 38262233Digital Resources/Online E-Resources |
| 19 |
Material Type: Article
|
|
Uterine cancer among Asian Americans - Disparities & clinical characteristicsGynecologic oncology, 2024-03, Vol.182, p.24 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.12.023 ;PMID: 38246043Digital Resources/Online E-Resources |
| 20 |
Material Type: Article
|
|
5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancerGynecologic oncology, 2024-03, Vol.182, p.82 [Peer Reviewed Journal]Copyright © 2024 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2024.01.001 ;PMID: 38262243Digital Resources/Online E-Resources |
Results 1 - 20 of 13,771 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 1983 (433)
- 1983 To 1992 (1,961)
- 1993 To 2002 (3,249)
- 2003 To 2013 (5,168)
- After 2013 (2,961)
-
More options
New Records
Subject
- Humans (13,350)
- Female (13,311)
- Oncology (13,272)
- Obstetrics & Gynecology (13,172)
- Life Sciences & Biomedicine (13,172)
- Science & Technology (13,172)
- Middle Aged (7,428)
- Adult (6,516)
- Aged (5,802)
- Obstetrics And Gynecology (5,618)
- Biological And Medical Sciences (4,925)
- Medical Sciences (4,916)
- Hematology, Oncology And Palliative Medicine (4,500)
- Gynecology. Andrology. Obstetrics (3,633)
- Tumors (3,525)
- Female Genital Diseases (3,438)
- Neoplasm Staging (3,163)
- Ovarian Neoplasms - Pathology (2,604)
- Aged, 80 And Over (2,498)
- Retrospective Studies (2,307)
-
More options
Databases
Language
- Japanese (2,295)
- Norwegian (7)
-
More options
Journal Title
- Cervical. Cancer. Immunotherapy Study Group. Gynecol. Oncol (1)
- Genecol Oncol (1)
- Gnecol Oncol (1)
- Gymecol Oncol (1)
- Gyn Oncology (1)
- Gyn. Oncol (2)
- Gynecol Oncol (507)
- Gynecol. Oncol (85)
- Gynecol. Oncol.; (50)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||